Knockdown of either Nrp1 or p130Cas, or alternatively expression of either Nrp1 without its cytoplasmic domain or a non-functional p130Cas mutant, all reduced the GF-induced migration of endothelial cells and glioma cells [45]. The gene discussed is NRP1; the disease is glioma.